RemeGen Co., Ltd. (REGMF) Financials

REGMF Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 1.4 billion 213.4 million
March 31, 2026 1.1 billion 495.3 million
Dec. 31, 2025 1.0 billion 507.7 million
Sept. 30, 2025 839.2 million 513.5 million

REGMF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 612.0 million ?
March 31, 2026 -4.5 million ?
Dec. 31, 2025 -26.3 million ?
Sept. 30, 2025 56.8 million ?

REGMF Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 635.4 million
March 31, 2026 47.0 million
Dec. 31, 2025 177.5 million
Sept. 30, 2025 -14.2 million

REGMF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 757.1 million 2.6 million 10.3 million
March 31, 2026 395.7 million 94.0 million 13.7 million
Dec. 31, 2025 346.4 million 104.7 million 2.8 million
Sept. 30, 2025 165.6 million 97.7 million 3.5 million

REGMF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 82.8 million
March 31, 2026 80.9 million
Dec. 31, 2025 78.3 million
Sept. 30, 2025 78.9 million

REGMF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 4.3 million 26.5 million 65.2 million -
March 31, 2026 6.5 million 30.1 million 50.1 million -
Dec. 31, 2025 3.6 million 6.1 million 8.2 million -
Sept. 30, 2025 7.9 million 34.2 million 52.2 million -

REGMF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 761.8 million 26.4 million
March 31, 2026 94.0 million 16.8 million
Dec. 31, 2025 215.6 million 27.4 million
Sept. 30, 2025 86.7 million 13.4 million

REGMF

Price: $9.96

52 week price:
5.06
12.85

Earnings Per Share: 1.55 USD

P/E Ratio: 7.05

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 5.6 billion

Links: